Search Results - "Giménez Manzorro, Á"

Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co‐administration by Lorenzo‐Pinto, A., Giménez‐Manzorro, Á., Rodríguez‐González, C. G., Ahumada‐Jiménez, A., Herranz‐Alonso, A., Marzal‐Alfaro, M. B., Sanjurjo‐Sáez, M.

“…Summary What is known and objective Limited data are available on co‐administration of acenocoumarol with direct‐acting antiviral agents for chronic hepatitis…”
Get full text

2SPD-007 Use of drugs in special situations by Montero Antón, MDP, González-Haba Peña, E, Giménez Manzorro, Á, Martín Barbero, ML, Villanueva Bueno, C, Romero Jiménez, R, Rioja Díez, Y, Herranz Alonso, A, Sanjurjo Sáez, M

“…Background and ImportanceThe use of medications in special situations is a common practice worldwide, even though it is a field with very few published studies…”
Get full text

Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice by Revuelta‐Herrero, J. L., Giménez‐Manzorro, A., Matilla‐Peña, A., Herranz‐Alonso, A., Sanjurjo‐Sáez, M.

“…Summary What is known and objective No studies have evaluated the use of sorafenib with the direct‐acting antiviral ombitasvir/paritaprevir/ritonavir and…”
Get full text

5PSQ-136 A pharmaceutical care programme in patients undergoing cardiac surgery by Ibañez Garcia, S, Garcia Gonzalez, X, Ribed Sanchez, A, de Lorenzo-Pinto, A, Giménez Manzorro, A, Ortega-Navarro, C, Marzal Alfaro, B, Garcia Martin, E, Herranz Alonso, A, Sanjurjo Sáez, M

“…BackgroundThe preoperative setting is an area with high risk for medication errors with potentially severe consequences. Strategies to reduce the incidence of…”
Get full text

5PSQ-070 Safety strategies to improve drug labelling in operating rooms by Melgarejo-Ortuño, A, Ribed-Sánchez, A, Bermejo-Albares, ML, García-García, A, Giménez-Manzorro, Á, Amor-García, MÁ, Narrillos-Moraza, Á, García-Sánchez, S, García-Moreno, F, Herranz-Alonso, A, Sanjurjo-Saez, M

“…Background and importanceOperating rooms (OR) are an area with a significant proportion of high risk, high alert medications. A new law was passed in 2016 in…”
Get full text

Implementation of an enhanced recovery after surgery program including a patient school: Impact on quality of life results by Somoza-Fernández, B, Ribed-Sánchez, A, Martín-Lozano, S, de Vega-San Vicente, FM, Menéndez-Tarín, R, Giménez-Manzorro, Á, Sanz-Ruiz, P, Garutti-Martínez, I, Herranz-Alonso, A, Vaquero-Martín, J, Sanjurjo-Sáez, M

“…•Patients’ involvement in their own surgical process in the context of the implementation of a patient school, showed optimal patient satisfaction rates and…”
Get full text

5PSQ-071 Evaluation of the effectiveness and safety of vedolizumab for the treatment of inflammatory bowel disease by Amor, MÁ, Lobato-Matilla, E, Giménez-Manzorro, Á, García-González, X, García-Martín, E, Melgarejo-Ortuño, A, Revuelta-Herrero, JL, Martínez-Ortega, PA, Ortega-Navarro, C, Herranz-Alonso, A, Sanjurjo-Sáez, M

“…BackgroundVedolizumab seems to be an alternative in the treatment of inflammatory bowel disease (IBD), but it needs real-world data to assess its…”
Get full text

PP390 EFFECT OF TWO INTRAVENOUS LIPID EMULSIONS ON IMMUNOLOGICAL PARAMETERS IN ADULT PATIENTS RECEIVING TOTAL PARENTERAL NUTRITION IN THE ABDOMINAL SURGERY UNIT by Escudero Vilaplana, V, Romero Jiménez, R.M, de Lorenzo Pinto, A, Giménez Manzorro, A, Muñoz Ruiz de Azúa, M, Cortejoso Fernández, L, Garcia Lopez, I, Pernía Lopez, S, Sanjurjo Saez, M

Get full text

CP-119 Questions about the new direct acting antiviral agents by Marquez, AM Gomez, de Vega, E Chamorro, Manzorro, A Gimenez, Gonzalez, C Rodriguez, Rodriguez, S Manrique, Jimenez, R Romero, Fernandez-Llamazares, C Martinez, Pozo, M Tovar, Alonso, A Herranz, Saez, M Sanjurjo

“…BackgroundThe marketing of direct acting antiviral agents (DAAs) has meant a great revolution in the treatment of chronic hepatitis C virus (HCV) infection…”
Get full text

CP-163 Onco-haematological outpatients treated with oral antineoplastic agents: pharmacist interventions by Escudero-Vilaplana, V, Collado-Borrell, R, Giménez-Manzorro, A, Ortega-Navarro, C, de Vega, E Chamorro, Ruiz-Martínez, C, Rodríguez-González, C, Herranz-Alonso, A, Sanjurjo-Sáez, M

“…BackgroundCurrently, oral antineoplastic agents (OAA) represent approximately 40% of all chemotherapy agents. Thus, onco-haematological outpatients have…”
Get full text

CP-066 Decreased inr after acenocoumarol and ombitasvir/paritaprevir/ritonavir co-administration by De Lorenzo-Pinto, A, Rodríguez-González, CG, Giménez-Manzorro, A, Manrique-Rodríguez, S, Ibáñez-García, S, Escudero-Vilaplana, V, Marzal-Alfaro, B, Herranz-Alonso, A, Revuelta-Herrero, JL, Sanjurjo-Sáez, M

“…BackgroundLimited data are available regarding co-administration of acenocoumarol with direct acting antiviral agents.PurposeWe report a case of a patient who…”
Get full text

DI-054 Safety results of direct acting antivirals for the treatment of hepatitis C virus infection by Lallana-Sáinz, E, Giménez-Manzorro, A, Ruiz-Martínez, C, Vega, E Chamorro de, Ribed, A, Alfaro, B Marzal, Sarobe-González, C, Tovar-Pozo, M, Herranz-Alonso, A, Sanjurjo-Sáez, M

“…BackgroundThe recent development of new drugs has changed radically the treatment of chronic hepatitis C virus (HCV) infection, from interferon (IFN) based…”
Get full text

Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co-administration by de Lorenzo-Pinto, A., Giménez-Manzorro, Á., Rodríguez-González, C. G., Ahumada-Jiménez, A., Herranz-Alonso, A., Marzal-Alfaro, M. B., Sanjurjo-Sáez, M.

Get full text

Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co-administration by de Lorenzo-Pinto, A, Giménez-Manzorro, Á, Rodríguez-González, C G, Ahumada-Jiménez, A, Herranz-Alonso, A, Marzal-Alfaro, M B, Sanjurjo-Sáez, M

“…WHAT IS KNOWN AND OBJECTIVELimited data are available on co-administration of acenocoumarol with direct-acting antiviral agents for chronic hepatitis C virus…”
Get full text

Analysis of prescriptions given on discharge from the emergencies department. Economic impact by Ruiz-López, J, Calleja Hernández, M A, Giménez Manzorro, A, Sanjurjo Sáez, M

“…To analyse the characteristics and cost of medical prescriptions given upon discharge from the casualty department, as well as the savings made by making…”
Get full text

Drug-related interventions made through a computerized prescription order entry system in an Internal Medicine unit by Durán García, M E, Pérez Sanz, C, Jiménez Muñoz, A B, Giménez Manzorro, A, Muiño Miguez, A, Alvarez-Sala Walter, L A, Sanjurjo Sáez, M

“…The objective of this article is to describe the drug-related interventions made in the prescriptions with a computerized order entry system and to determine…”
Get more information

4CPS-240 Adding value: pharmacist interventions in the perioperative setting by Ribed, A, Gimenez-Manzorro, A, Lorenzo, A de, Zorrila, J, Ortega, C, Herranz-Alonso, A, Sanjurjo, M

“…BackgroundSurgery complications are a hospital quality indicator.PurposeThe aim is to describe the interventions in a perioperative pharmaceutical care…”
Get full text

5PSQ-048 Analysis of drug interactions between oral antineoplastic agents and concurrent medications by Narrillos-Moraza, A, Escudero-Vilaplana, V, Collado-Borrell, R, Hoyo-Muñoz, A, Gimenez-Manzorro, A, Amor-Garcia, MA, Osorio-Prendes, S, Calles-Blanco, A, Herranz-Alonso, A, Sanjurjo-Saez, M

“…Background and importanceThe development and commercialisation of oral antineoplastic agents (OAAs) to treat cancer has increased significantly in recent…”
Get full text

4CPS-168 Postoperative pain management and pain referred by adult patients 24 hours after surgery and one month after discharge by Martinez Ortega, P, Gimenez-Manzorro, A, Ribed-Sanchez, A, de Lorenzo-Pinto, A, Garcia-Martin, E, Garcia-Sanchez, S, Amor-Garcia, MA, Garcia-Moreno, FJ, Melgarejo-Ortuño, A, Herranz-Alonso, A, Sanjurjo-Saez, M

“…BackgroundInappropriate pain management during the surgical process could lead to worse surgery outcomes and quality of life. Hospital pharmacists should…”
Get full text

Análisis de la prescripción al alta en urgencias. Impacto económico by Ruiz-López, J., Calleja Hernández, M.A., Giménez Manzorro, A., Sanjurjo Sáez, M.

“…Analizar las características y coste de la prescripción medicamentosa al alta en urgencias, así como el ahorro que supondría la sustitución por su EFG u otra…”
Get full text